ArticleSAGE open medicine2026
Prevalence of electrocardiographic abnormalities and predictors of QTc prolongation in patients with diabetic ketoacidosis: A retrospective cohort study.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To determine the prevalence of electrocardiographic (ECG) abnormalities in diabetic ketoacidosis (DKA) patients, evaluate their associations with metabolic parameters, and identify independent predictors of clinical outcomes. Methods: This retrospective study included 374 DKA patients (2012-2023). Baseline clinical characteristics, laboratory data, and initial ECG findings were analyzed. Multivariable logistic regression was performed to assess associations between metabolic parameters and corrected QT (QTc) prolongation, as well as clinical outcomes. Results: Sinus tachycardia occurred in 54.8%, while QTc prolongation was found in 64.7% of patients using Bazett's formula versus 27.5% using Fridericia's correction. In multivariable analysis, lower serum bicarbonate levels were independently associated with QTc prolongation using both formulas (Bazett's: adjusted OR 0.92, 95%CI 0.87-0.98, p=0.007; Fridericia's: adjusted OR 0.91, 95%CI 0.85-0.97, p=0.002). These associations remained consistent across different QTc thresholds, including high-risk and very high-risk QTc prolongation. However, QTc prolongation was not independently associated with length of stay or in-hospital mortality. Conclusions: QTc prolongation was frequently observed in patients with DKA and showed an association with the severity of metabolic acidosis, particularly reduced serum bicarbonate levels. Given its potential implication for arrhythmogenic risk, careful ECG assessment and monitoring should be considered during the initial evaluation and management of DKA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.